sickle
- Business
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
The U.S. Food and Drug Administration on Friday favorite the country’s first gene-editing treatment, Casgevy, to be used in sufferers…
Read More »
By using our website, you consent to the use of cookies and other tracking technologies as described in our privacy policy.
The U.S. Food and Drug Administration on Friday favorite the country’s first gene-editing treatment, Casgevy, to be used in sufferers…
Read More »